NextNRG Reports Q2 2025 Revenues Up 166% Year-Over-Year

NextNRG Reports Q2 2025 Revenues Up 166% Year-Over-Year GlobeNewswire August 15, 2025 Record-Breaking Growth Highlights Execution of Integrated Energy Infrastructure Strategy Strong Operational Metrics Drive 189% Gross Profit Growth as Multi-Revenue Platform Scales MIAMI, Aug. 15, 2025 (GLOBE NEWSWIRE) — NextNRG, Inc. (NASDAQ: NXXT), a pioneer in AI-driven energy innovation–transforming how energy is produced, managed […]

American Rare Earths Announces SynBREE Consortium Produces Heavy & Light Rare Earths Oxide Concentrates using Halleck Creek Ore

American Rare Earths Announces SynBREE Consortium Produces Heavy & Light Rare Earths Oxide Concentrates using Halleck Creek Ore GlobeNewswire August 15, 2025 Highlights Mixed heavy and light rare earth oxide concentrates produced from Halleck Creek's allanite-based ore as part of the US Department of Defense's (“DoD”) on-going Defense Advanced Research Projects Agency (“DARPA”) Environmental Microbes

DeFi Dev Corp. Purchases $22M SOL, Grows Treasury to 1.42M SOL

DeFi Dev Corp. Purchases $22M SOL, Grows Treasury to 1.42M SOL GlobeNewswire August 15, 2025 BOCA RATON, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced it now holds approximately 1,420,173 SOL and

CISO Global Achieves 108% Gross Profit Growth, 56% Net Loss from Operations Reduction, and Momentum from Strategic Partnerships

CISO Global Achieves 108% Gross Profit Growth, 56% Net Loss from Operations Reduction, and Momentum from Strategic Partnerships GlobeNewswire August 15, 2025 Scottsdale, AZ, Aug. 15, 2025 (GLOBE NEWSWIRE) — CISO Global (NASDAQ: CISO), a leading provider of AI-powered cybersecurity software and compliance services, announces strong profit growth, margin expansion, and a healthier balance sheet.

Bel Fuse Announces Participation in the 16th Annual Midwest IDEAS Conference

Bel Fuse Announces Participation in the 16th Annual Midwest IDEAS Conference GlobeNewswire August 15, 2025 WEST ORANGE, N.J., Aug. 15, 2025 (GLOBE NEWSWIRE) — Bel Fuse Inc. (Nasdaq: BELFA and BELFB), a leading global manufacturer of products that power, protect and connect electronic circuits, today announced its participation in the 16th Annual Midwest IDEAS Conference:

Global Clinical Trial Supplies Market to Reach USD 8.18 Billion by 2030 | MarketsandMarkets(TM)

Global Clinical Trial Supplies Market to Reach USD 8.18 Billion by 2030 | MarketsandMarkets(TM) GlobeNewswire August 15, 2025 Delray Beach, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) — Innovations in supply chain management and the rise of direct-to-patient models are transforming how life sciences companies execute global clinical trials.The global clinical trial supplies market, valued at

YY Group Reports 65% Quarterly Growth in UAE and Expands Operations to Perth, Australia

YY Group Reports 65% Quarterly Growth in UAE and Expands Operations to Perth, Australia GlobeNewswire August 15, 2025 Singapore, Aug. 15, 2025 (GLOBE NEWSWIRE) — YY Group Holding Limited (NASDAQ: YYGH) (“YY Group,” “YYGH,” or the “Company”), a global leader in on-demand workforce solutions and integrated facility management (IFM), today announced the official launch of

Sienna Announces August Dividend

Sienna Announces August Dividend GlobeNewswire August 15, 2025 MARKHAM, Ontario, Aug. 15, 2025 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company“) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share“) for the month of August 2025, representing $0.936 per Common Share on an

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire August 15, 2025 SOUTH SAN FRANCISCO, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee

Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies

Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies GlobeNewswire August 15, 2025 Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential

Scroll to Top